Back
Atara Biotherapeutics Stock Price Chart
Sponsored
ATRA
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
ATRA
Atara Biotherapeutics
Last Price:
$13.17
Seasonality Move:
10.83%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Atara Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.7 | Buy |
20-day SMA: | 11.74 | Buy |
50-day SMA: | 10.8 | Buy |
200-day SMA: | 11.7 | Buy |
8-day EMA: | 11.14 | Buy |
20-day EMA: | 11.31 | Buy |
50-day EMA: | 10.82 | Buy |
200-day EMA: | 14.17 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 56.81 | Buy |
Chaikin Money Flow: | 70575 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.63 - 12.57) | Buy |
Bollinger Bands (100): | (7.42 - 11.22) | Buy |
Atara Biotherapeutics Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 12.20 while ATRA 8-day simple moving average is 10.70, which is a Buy signal.
-
The stock price of ATRA is 12.20 while Atara Biotherapeutics 20-day SMA is 11.74, which makes it a Buy.
-
Atara Biotherapeutics 50-day simple moving average is 10.80 while ATRA share price is 12.20, making it a Buy technically.
-
ATRA stock price is 12.20 and Atara Biotherapeutics 200-day simple moving average is 11.70, creating a Buy signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
41
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a SellThe current Atara Biotherapeutics [ATRA] share price is $12.20. The Score for ATRA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
70.3M
Price in USD:
12.20
Share Volume:
130.4K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Sell
41
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 12.20 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 12.20 while ATRA 8-day exponential moving average is 11.14, which is a Buy signal.
-
The stock price of ATRA is 12.20 while Atara Biotherapeutics 20-day EMA is 11.31, which makes it a Buy.
-
Atara Biotherapeutics 50-day exponential moving average is 10.82 while ATRA share price is 12.20, making it a Buy technically.
-
ATRA stock price is 12.20 and Atara Biotherapeutics 200-day simple moving average is 14.17, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $61.17 per share, and a decrease next year of $10.45 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Atara Biotherapeutics is a Sell
-
Atara Biotherapeutics Relative Strength Index (RSI) is 56.81, which suggest Atara Biotherapeutics is overbought
-
The Bollinger Bands (25) for Atara Biotherapeutics is (10.63 - 12.57), which suggest Atara Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Atara Biotherapeutics is (7.42 - 11.22), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.